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ABSTRACT
Aims To estimate the short-term effectiveness, feasibility and acceptability of a smoking cessation intervention (the
iQuit system) that consists of tailored printed and Short Message Service (SMS) text message self-help delivered as an
adjunct to cessation support in primary care to inform the design of a definitive trial. Design A stratified two
parallel-group randomized controlled trial comparing usual care (control) with usual care plus the iQuit system
(intervention), delivered by primary care nurses/healthcare assistants who were blinded to the allocation sequence.
Setting Thirty-two general practice (GP) surgeries in England, UK. Participants A total of 602 smokers initiating
smoking cessation support from their local GP surgery were randomized (control n = 303, intervention n = 299).
Measurements Primary outcome was self-reported 2-week point prevalence abstinence at 8 weeks follow-up. Sec-
ondary smoking outcomes and feasibility and acceptability measures were collected at 4 weeks after quit date, 8 weeks
and 6 months follow-up. Findings There were no significant between-group differences in the primary outcome
[control 40.3%, iQuit 45.2%; odds ratio (OR) = 1.22, 95% confidence interval (CI) = 0.88–1.69] or in secondary
short-term smoking outcomes. Six-month prolonged abstinence was significantly higher in the iQuit arm (control
8.9%, iQuit 15.1%; OR = 1.81, 95% CI = 1.09–3.01). iQuit support took on average 7.7 minutes (standard devia-
tion = 4.0) to deliver and 18.9% (95% CI = 14.8–23.7%) of intervention participants discontinued the text message
support during the programme. Conclusions Tailored printed and text message self-help delivered alongside routine
smoking cessation support in primary care does not significantly increase short-term abstinence, but may increase
long-term abstinence and demonstrated feasibility and acceptability compared with routine cessation support alone.
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INTRODUCTION
Primary care is an important setting for smoking cessa-
tion interventions [1,2]. However, the implementation
and intensity of cessation support offered and delivered
varies widely between countries [2]. Tailored self-help
interventions could be used to augment cessation support
in healthcare settings and are recommended for use in
primary care [3,4]. A Cochrane Review of self-help inter-
ventions for smoking cessation [5] identified a small
benefit of tailored self-help materials compared to stand-
ardmaterials or no intervention [n = 28 189; relative risk
(RR) = 1.31, 95% confidence interval (CI) = 1.20–1.42].
However, the potential benefit of adding tailored self-help
to routine cessation support in primary care has not yet
been assessed.
Studies have shown that Short Message Service (SMS)
text messaging smoking cessation interventions outside
primary care are feasible and acceptable [6,7], but data
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on effectiveness, particularly in the longer term, are
limited. A recent Cochrane Review [8] found a benefit for
mobile cessation interventions compared with minimal
or no intervention controls (n = 9100; RR = 1.71, 95%
CI = 1.47–1.99). The largest trial included in this review
(txt2stop) [9] found that abstinence rates in the text mes-
saging arm were twice that of a no intervention control
arm at the 6-month follow-up (RR = 2.20, 95%
CI = 1.80–2.68). However, among a subgroup of partici-
pants who reported using a smoking cessation product or
service at baseline there was a non-significant difference
between trial arms (RR = 1.51, 99% CI = 0.90–2.55).
Currently, there is uncertainty about the potential addi-
tive benefits of text message support, alone or combined
with other self-help, on top of pharmacological and/or
face-to-face cessation support.
The iQuit system evaluated in the current study has
been informed by several tailored cessation systems,
which have been evaluated in trials with mixed results.
Tailored advice letters/reports generated by these earlier
systems were found to increase abstinence among
smokers when delivered as an adjunct to telephone coun-
selling andgeneric self-helpmaterials [10], butnot signifi-
cantly when compared to non-tailored information only
among smokers recruited via general practice (GP) [11]
and online [12]. Expanding intervention delivery to
mobilephones,wedevelopedandevaluatedapilot tailored
text message intervention for pregnant smokers, which
had high acceptability and increased hypothesized deter-
minants of abstinence [7]. These tailored systems demon-
strated enhanced perceived personal relevance of the
information received and the likelihood that it would be
read [7,10,13], in line with hypothesized mechanisms of
tailoring [14,15]. The iQuit system builds on these inter-
ventions; it is a programme designed to be used by a
primary care nurse or other smoking cessation adviser
(SCA),whichgenerates ahighly tailoredadvice report and
initiates a 90-day programme of automated tailored text
messages sent to the smoker’s mobile phone. The iQuit
system is the first digital self-help tool designed for use by
SCAs and, unlikemost other textmessaging programmes,
delivers text support that is highly tailored to the smoker.
The aims of this study were to estimate the short-term
effectiveness of the iQuit intervention compared with
usual care alone, to assess the acceptability of the inter-
vention to participants and to assess the feasibility of the
intervention and of aspects of the trial design and proce-
dures to inform the design of a definitive trial.
METHOD
Design and randomization
This was a two parallel-group randomized controlled trial
with 1 : 1 individual allocation comparing usual care
(control) with usual care plus the iQuit system (interven-
tion). Randomization was stratified by SCA. The alloca-
tion sequence was generated by a computer-based
random number generator using random permuted
blocks with block sizes of four and six, stored on a remote
web server. The sequence was accessible to the investiga-
tors, who had no involvement in recruitment at partici-
pating sites. The sequence was not accessible to the SCAs
or participants. Allocation was made by the web server
during the consultation once Part 1 of the iQuit question-
naire was submitted (see Procedure). At this point, the
SCA and the participant were unblinded to allocation.
Recruitment
Recruitment: practices
General practices with at least one SCA (primary care
nurse or healthcare assistant, a nursing auxiliary under
the guidance of a qualified healthcare professional)
trained to give ‘level 2’ smoking cessation advice (see
Interventions) with internet and printer access from their
consultation room(s) were eligible. Initially, practices
close to Cambridge were approached, but due to slow
practice recruitment this area was extended to the whole
of the East of England. One hundred and eighteen prac-
tices were contacted directly by the researchers between
September 2009 and March 2011. Of the 104 eligible
practices approached, 32 participated (30.8%) (see
Fig. 1). Mean list size for participating practices was
10 538 [standard deviation (SD) = 3638]. A deprivation
measure, which combines 37 indicators of deprivation
into a summary score (Index of Multiple Deprivation:
IMD) [16], indicated that eight practices were in the top
50% of deprived small geographical areas in England
(Lower Super Output Areas) (mean IMD score for study
practices 13.7; range 3.0–27.7; SD = 7.0).
Recruitment: participants
Patients were eligible for inclusion if they met the follow-
ing criteria: current smoker (usually smokes at least one
cigarette a day, has smoked in the 7 days prior to
randomization); able to read English and provide written
informed consent; willing to set a quit date within 14
days after randomization; aged 18–75 years; has amobile
phone and is familiar with sending and receiving text
messages; not enrolled in another formal smoking cessa-
tion study or programme; and not using smoking cessa-
tion medications at randomization date.
Participants were primarily recruited opportunisti-
cally, through self-referral or referred by a health profes-
sional, to receive smoking cessation advice. Practices
were also encouraged to post study information to a
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a Estimate based on 31 smoking cessation advisors who provided reliable screening data
Number of smokers screeneda n = 776
Excluded - did not meet inclusion criteriaa n = 
174 (22.4%)
Does not own a mobile phone/unfamiliar with 
text messaging n = 73
Already using a smoking cessation medication 
n = 32
Unable to follow study procedures n = 17
Not aged between 18-75 years n = 10
Unable to set a quit date within 14 days n = 9
Not a current smoker n = 5
Unable to read written English n = 2
Other/unknown n = 26
Randomised n = 602 (77.6%)
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Allocated to intervention arm n = 299
Subsequently withdrew from trial n = 2
Allocated to control arm n = 303
Subsequently withdrew from trial n = 0
Analysed n = 303
Lost to follow-up (non-cumulative)
4-weeks lost to follow-up n = 80 (26.8%)
Did not attend appointment or could not be 
reached n = 80
8-weeks lost to follow-up n = 42 (14.0%)
No response to contact n = 19
Participant unobtainable n = 4
Other n = 19
6-months lost to follow-up n = 70 (23.4%)
No response to contact n = 33
Participant unobtainable n = 11
Other n = 26
Lost to follow-up (non-cumulative)
4-weeks lost to follow-up n = 97 (32%)
Did not attend appointment or could not be 
reached n = 97
8-weeks lost to follow-up n = 55 (18.2%)
No response to contact n = 22
Participant unobtainable n = 13
Other n = 20
6-months lost to follow-up n = 65 (21.5%)
No response to contact n = 26
Participant unobtainable n = 12
Other n = 27
A
do
pt
io
n
Eligible general practices contacted by researchers 
= 104
Did not participate = 72 (69.2%)
Declined = 32 (30.8%)
Did not return contact = 40 (38.5%)
Practices agreeing to participate = 32 (30.8%)
Figure 1 Trial flow.
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random selection of patients identified as smokers
from their practice database. See Protocol for further
information [17].
Interventions
Control
‘Usual care’ consisted of routine ‘level 2’ smoking cessa-
tion advice delivered by SCAs [18]. This included a brief
discussion about smoking habits and history, measure-
ment of expired-air carbon monoxide (CO) (using a sup-
plied Bedfont piCO Smokerlyzer, Maidstone, UK), brief
advice to quit, setting a quit date within the next 14 days,
options for pharmacotherapy, a prescription and arrang-
ing a follow-up visit. Usually the opportunity for multiple
follow-up visits was offered.
Intervention
The intervention consisted of usual care, as described
above, plus a tailored advice report and a programme of
tailored text messages generated by the iQuit system. The
content of the report and text messages were based on
relevant theories of smoking cessation and behaviour
change, including social cognitive theory [19] and the
perspectives on change model [20], and informed by pre-
vious research [10] and extensive qualitative work with
smokers [21,22]. The iQuit programmewas piloted in five
general practices in Cambridgeshire. See Supporting
information for detailed information about iQuit support.
Advice report. The four-page advice report contained
detailed advice on quitting tailored to 25 items from the
programme’s 30-item questionnaire including: smoking
habits and history; motivation and determination to quit;
reasons for quitting; dependence; self-image; pros and
cons of quitting; perceived difficult situations; children;
living with other smokers; social support; and current
health problems.
Text messaging. The text messaging component consisted
of a 90-day programme of automated text messages sent
to the smoker’s mobile phone. The messages started the
day before the participant’s quit date. The number of
messages sent each day varied according to the pre-
determined schedule (see Supporting information) and
was either 0, 1 or 2 (mean per day over 90 days 1.2). The
messages were designed to advise smokers on their quit
attempt, provide information about the consequences of
smoking and expectations for quitting, provide encour-
agement, boost self-efficacy, maintain motivation to quit
and remind smokers how to cope with difficult situations.
The text messages were tailored individually using 24
items from the iQuit questionnaire and information
obtained from query messages about smoking status sent
to the participant at 3 and 7 weeks after their quit date.
Intervention participants could also text HELP or SLIP to
immediately receive a support message if they were
tempted to smoke (HELP) or had just had a lapse (SLIP).
Intervention participants could text STOP to discontinue
all text messages.
Procedure
After the patient had been screened for eligibility by the
SCA and consent taken, the SCA provided smoking ces-
sation advice, as per usual practice. The SCA then logged
on to the online iQuit program via the practice computer
using a unique login and completed part 1 of the iQuit
questionnaire with all participants. This included basic
demographic and smoking-related information, quit date
and CO level. Once part 1 of the iQuit questionnaire was
completed, the participant was randomized by the online
program either to the control group and asked no further
questions or to the intervention group and asked a second
set of questions (part 2), focusing on key tailoring vari-
ables. Once part 2 was completed, the iQuit program gen-
erated a tailored advice report. The report was then
printed out by the SCA, handed to the intervention par-
ticipant and the consultation concluded. Subsequent
appointments were undertaken by an SCA as per usual
care.
Participants were followed-up by an SCA, although
not always the same one seen at the first visit, 4 weeks
after their quit date, as per usual care, and by postal ques-
tionnaire from the study centre at 8 weeks and 6 months
after randomization. Non-responders to the postal ques-
tionnaire were contacted by telephone by a researcher,
initially blinded to allocation, and given a choice of
returning the questionnaire by post or completing it over
the telephone. Participants unwilling to complete the full
questionnaire were asked to complete the smoking out-
comes questions only. Up to six attempts were made to
contact participants by telephone at each follow-up.
To compensate for any study-related text messaging
costs, intervention participants were sent a £5 voucher
with the 8-week follow-up questionnaire.
Outcome measures
Effectiveness
The primary outcome measure was self-reported 2-week
point prevalence abstinence at 8-week follow-up from
randomization date. This outcome was chosen because it
represented a short-term period which would not inter-
fere with the routine 4-week follow-up from quit date.
Secondary outcome measures included CO-verified absti-
nence at 4-week follow-up from quit date for at least 2
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weeks, assessed by an SCA [using the England NHS Stop
Smoking Services (SSS) definition [23]: a CO reading
assessed 25 to 42 days from quit date that is less than 10
parts permillion]. Self-reported 3-month prolonged absti-
nence at 6-month follow-up from randomization date
was also a secondary outcome measure. In addition to
pre-specified outcome measures, two longer-term
smoking outcomemeasures were assessed [24]; 6-month
prolonged abstinence at 6-month follow-up and a strict
continuous abstinence measure using all outcome time-
points: CO-validated 2-week point prevalence abstinence
at 4 weeks, 4-week point prevalence abstinence at 8
weeks and 6-month prolonged abstinence at 6 months.
These long-term measures deviated from the Russell
Standard, aswe did not allow participants to have smoked
any cigarettes during the abstinence period, abstinence
was not verified biochemically andwe could not avoid the
possibility that some assessors at the 6-month follow-up
became unblinded to allocation. Use of cessation medica-
tion was also assessed at all follow-ups.
Feasibility and acceptability
Feasibility measures included the number of smokers per
practice recruited, response rates to follow-up question-
naires, time taken to complete the online questionnaire,
increase in length of consultation and participant’s per-
ceived ease of answering the iQuit questionnaire.
Acceptability measures included evaluation of the
advice report and text messages and the proportion of
intervention participants who discontinued text support
by texting STOP.
Sample size and analysis
For effectiveness, the study was powered on point preva-
lence abstinence for 2 weeks at the 8-week follow-up. A
sample size of 300 per group would give 80% power to
detect an increase in abstinence from 20 to 30%
(alpha = 0.05, two-sided test), informed by a systematic
review showing a relative increase in abstinence among
smokers receiving tailored materials versus no materials
of 40% at 6 months [5]. The 20% control rate at 8 weeks
was estimated from the same review’s subgroup analysis
where controls, who received face-to-face advice without
self-help, had a pooled long-term quit rate of 8% [5]. This
sample size was also chosen because it provided a 95% CI
width of ± 5% for the between-arm difference in 6-month
abstinence, based on an anticipated control group rate of
8% [5]. This CI was used to calculate the probability that
the intervention would produce an intervention effect
equivalent to a relative risk of at least 1.2 (small effect
size), or at least 1.5 (medium effect size), to inform the
decision to proceed to a definitive trial.
Groups were compared using χ2 tests and logistic
regression analysis for binary outcome measures, and
independent t-tests, analysis of variance and linear
regression analysis for continuous measures and Fisher’s
exact test and 95% CI by the Clopper–Pearsonmethod for
between-group proportions. Single arm proportions were
estimated with exact 95% CI using the binomial distribu-
tion. The group difference in prolonged abstinence at
6-month follow-up was assessed using a Bayesian poste-
rior 95% credibility interval for the absolute difference
between trial arms. The smoking outcome analyses were
intention-to-treat, where all those randomized were ana-
lysed with participants lost to follow-up assumed to be
smoking. We also conducted sensitivity analyses using a
range of less severe assumptions, namely a complete-case
analysis and relaxation of the 4-week abstinence
definition [25].
RESULTS
Recruitment, baseline characteristics and attrition
Of the 53 SCAs who recruited participants, 31 provided
reliable screening logs. Between these 31 SCAs, 455 indi-
viduals were screened, of whom 353 were eligible and
were recruited (77.6%). Assuming similar eligibility rates
among SCAs who did not provide reliable screening logs,
we estimate that 776 individuals would have been
screened to have recruited 602 individuals (Fig. 1). All
602 participants recruited were randomized. Partici-
pants had a mean age of 41.8 years (SD = 13.0) at base-
line and 52.7% were female. Two-thirds smoked within
30 minutes of waking and the mean daily smoking rate
was 18.3 (SD = 8.0) cigarettes (Table 1). Two partici-
pants withdrew from the trial. Attrition (non-
cumulative), defined as not obtaining smoking status or a
completed questionnaire by post or over the telephone
was 30.1% (4 weeks), 15.9% (8 weeks) and 22.3% (6
months) (Fig. 1). There were no between-group differ-
ences in attrition.
Smoking outcomes
There were no significant between-group differences in
2-week point prevalence abstinence at the 8-week
primary end-point [control 40.3%, iQuit 45.2%; odds
ratio (OR) = 1.22, 95% CI = 0.88–1.69] or in any sec-
ondary short-term abstinence outcomes (Table 2). Statis-
tically significant group differences were found for
6-month prolonged abstinence at 6 months (control
8.9%, iQuit 15.1%; OR = 1.81, 95%CI = 1.09–3.01) and
for 6-month continuous abstinence (control 6.3%, iQuit
11.4%; OR = 1.92, 95% CI = 1.07–3.45). A meta-
analysis indicated no observed heterogeneity between
practices of the intervention effect on 6-month
prolonged abstinence (Cochrane’s Q = 15.84, P = 0.99;
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I-squared = 0.0%). No group differences were found in
reported cessation medication use.
Feasibility
Per practice, the mean number of SCAs was 1.7 (range
1–3), the mean monthly recruitment rate was 1.9
(SD = 1.6) and the mean number of participants
recruited was 18.8 (range 1–40) (Table 3). Among
participants followed-up, a greater proportion in the
intervention group, compared to controls, completed
follow-up information by post (rather than by telephone)
(8 weeks: control 42.1%, iQuit 57.9%; P = 0.01; 6
Table 1 Baseline sample characteristics.
Control arma
n (%)
Interventiona arm
n (%)
Totala
n (%)
Female 158 (52.1) 159 (53.2) 317 (52.7)
Mean (SD) age 41.3 (13.0) 42.3 (13.0) 41.8 (13.0)
White ethnic group 297 (98.0) 293 (98.0) 590 (98.0)
Occupation category
Not working (student/home carer/retired) 45 (14.9) 53 (17.7) 98 (16.3)
Never worked/long-term unemployed 19 (6.3) 21 (7.0) 40 (6.6)
Sick/disabled 16 (5.3) 26 (8.7) 42 (7.0)
Routine and manual 89 (29.4) 93 (31.1) 182 (30.2)
Intermediate 30 (9.9) 21 (7.0) 51 (8.5)
Managerial/professional 82 (27.1) 74 (24.7) 156 (25.9)
Unknown 22 (7.3) 11 (3.7) 33 (5.5)
Mean (SD) number of cigarettes smoked per day 18.2 (8.2) 18.4 (7.9) 18.3 (8.0)
Smoked first cigarette within 30 minutes 196 (64.7) 213 (71.2) 409 (67.9)
Mean (SD) carbon monoxide in exhaled air p.p.m. 20.8 (11.5) 21.1 (12.7) 21.0 (12.1)
How much do you want to quit? (five-point scale) 4.5 (0.6) 4.5 (0.7) 4.5 (0.6)
Previously quit smoking for 3 months or longer 185 (61.1) 158 (52.8) 343 (57.0)
aPercentages may not add up to 100 due to rounding. SD = standard deviation; p.p.m. = parts per million.
Table 2 Smoking outcomes and use of cessation medication.
Control arm
n (%)
Intervention arm
n (%)
Absolute difference
(95% CI)
Odds ratio
(95% CI)a,b
Primary outcome
Self-reported 2-week point prevalence abstinence at
8-week follow-up
122 (40.3) 135 (45.2) 4.9% (−3.0 to 12.7%) 1.22 (0.88–1.69)
Secondary outcomes
CO-verified 2-week point prevalence abstinence at
4-week follow-up after quit datec
71 (23.4) 81 (27.1) 3.7% (−3.3 to 10.6%) 1.21 (0.84–1.76)
Self-reported 3-month prolonged abstinence at
6-month follow-up
70 (23.1) 76 (25.4) 2.3% (−4.5 to 9.1%)d 1.13 (0.78–1.65)
Additional outcomes
Self-reported 6-month prolonged abstinence at
6-month follow-up
27 (8.9) 45 (15.1) 6.1% (0.9 to 11.4%) 1.81 (1.09–3.01)
Continuous abstinence (4-week, 8-week and
6-month follow-ups)e
19 (6.3) 34 (11.4) 5.1% (0.6 to 9.8%) 1.92 (1.07–3.45)
Smoking cessation medication
SCA reported usage at 4-week follow-up after
quit datef
166 (79.4) 174 (79.5) 0.0% (−7.6 to 7.7%) 1.00 (0.63–1.60)
Self-reported usage at 8-week follow-upf 114 (55.6) 144 (62.3) 6.7% (−2.5 to 15.8%) 1.32 (0.90–1.94)
Self-reported usage at 6-months follow-upf 46 (21.6) 43 (20.9) −0.7% (−8.5 to 7.1%) 0.96 (0.60–1.53)
aUnadjusted odds ratios for smoking outcomes. Adjusting for baseline characteristics made no noticeable difference to findings. bSensitivity analyses did
not result in any noticeable differences in the findings. cParticipants whose self-reported abstinence was not carbon monoxide (CO)-validated or where
CO-validated smoking abstinence was recorded outside the National Health Service (NHS) 4-week assessment window (28 days after quit date, −3 to
+14) were counted as smokers. dBayesian posterior 95% credibility interval for the absolute difference between trial arms 2.3% (−4.5 to 9.2%). eCO
validated 2-week point prevalence abstinence at 4weeks, 4-week point prevalence abstinence at 8weeks and 6-month prolonged abstinence at 6months.
fDenominator restricted to those followed-up. SCA = smoking cessation adviser; CI = confidence interval.
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months: control 44.0%, iQuit 56.0%; P = 0.01). The
additional consultation time taken for intervention par-
ticipants using controls as a reference was 3.5 minutes
for the first visit and 0.4 minutes for the 4-week visit,
based on SCA self-report. Themean time taken by SCAs to
complete the online questionnaire, as recorded by the
programme, was 7.7 (SD = 4.0) minutes for intervention
participants and 3.0 (SD = 2.4) minutes for control par-
ticipants (mean difference 4.7, 95% CI = 4.2–5.2). Most
participants reported that completing the iQuit question-
naire with the SCA was extremely easy (mean on five-
point scale 4.6, SD = 0.7).
Acceptability
Most intervention participants reported that they found
the advice report useful (79.2%, see Table 4 for 95% CIs),
easy to understand (88.0%) and that it helped them to
quit smoking (65.2%). They found the text messages an
acceptable way of receiving smoking cessation support
(67.7%), useful (64.1%), easy to understand (93.7%) and
just fewer than half found that they helped them to quit
smoking (44.8%), although one in four found them
Table 3 Feasibility outcomes.
Mean (SD) 95% CI
Number of active SCAs per practicea 1.7 (0.5) 1.5–1.9
Monthly recruitment rate per
participating practice
1.9 (1.6) 1.4–2.5
Number of participants recruited per
practice
18.8 (11.0) 15.0–22.6
Number of participants recruited per
active SCAa
11.4 (9.4) 8.8–13.9
Time in minutes taken to complete
iQuit questionnaire and generate
report (intervention group only)b
7.7 (4.0) 7.3–8.2
Ease of answering online
questionnaire during
consultation (five point
scale) (intervention group only)
4.6 (0.7) 4.5–4.7
aActive smoking cessation advisers (SCAs) were those who recruited at
least one participant into the trial (n = 53). bBased on data collected by the
iQuit program. SD = standard deviation; CI = confidence interval.
Table 4 Acceptability, perceived value and use of iQuit support (intervention group only); proportion of participants who scored 4 or
5 on a five-point scale (1 = not at all, 5 = extremely) unless stated otherwise.
Percentages (frequencies) 95% CIa
Tailored advice report assessment at 8 weeks follow-up (denominator)
Found information useful (n = 202) 79.2 (160) 73.1–84.2
Felt the report was effective in helping them quit smoking (n = 204) 65.2 (133) 58.4–71.4
Found the report easy to understand (n = 200) 88.0 (176) 82.8–91.8
Read all the report at least once (n = 207) 69.6 (144) 63.0–75.4
Felt the report was too long (n = 201) 11.4 (23) 7.8–16.6
Tailored text messages assessment at 6 months follow-up (denominator)
Felt receiving support by text message acceptable (n = 192) 67.7 (130) 60.8–73.9
Found information in texts useful (n = 192) 64.1 (123) 57.1–70.5
Felt the texts were effective in helping them quit smoking (n = 192) 44.8 (86) 37.9–51.9
Found the texts easy to understand (n = 223)b 93.7 (209) 89.7–96.2
Felt they received too many texts (n = 192) 18.8 (36) 13.9–24.9
Found the texts irritating (n = 192) 25.5 (49) 19.9–32.1
Wish they never received any text messages (n = 192) 7.3 (14) 4.4–11.9
Felt the duration of the text programme was too long (n = 189) 13.2 (25) 9.1–18.9
Requested an instant support text (n = 297) 18.5 (55) 14.5–23.3
Number of instant support texts requested (n = 55)
Mean (SD) 4.2 (7.6) 2.2–6.3c
Median 2.0 NA
Found instant support texts useful (n = 49) 61.2 (30) 47.3–73.6
Discontinued the texts by texting STOP (n = 297) 18.9 (56) 14.8–23.7
Mean (SD) number of days into programme that STOP was sent by text 52.5 (18.9) 47.5–57.6c
Reasons why STOP was sent by text (n = 31)
Did not need any further support 25.8 (8) 13.7–43.3
The texts were beginning to annoy me 25.8 (8) 13.7–43.3
The texts were no longer benefitting me 29.0 (9) 16.1–46.6
Other 19.4 (6) 9.2–36.3
a95% confidence interval (CI) of the proportion. bCollected at 8-week follow-up. c95% CI of the mean; SD = standard deviation; NA = not applicable.
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annoying to some extent (25.5%). Of intervention par-
ticipants, 18.9% sent a STOP text message, on average
52.5 (SD = 18.9) days into the 90-day programme.
Around one-quarter of those who sent a STOP message
(representing approximately 5% of all intervention par-
ticipants) reported doing so due to annoyance.
Proceeding to a definitive trial
The relative risk for the long-term intervention effect at 6
months was 1.69 (95% CI = 1.08–2.65). Consequently,
the estimated probability that the intervention would
produce a small intervention effect equivalent to a RR of
at least 1.2 is 93%, and the probability of a medium effect
size of 1.5 is 70%.
DISCUSSION
This was the first study to evaluate the potential benefit of
adding a printed and text message cessation intervention
to routine smoking cessation support in primary care.We
did not find evidence of a short-term benefit of iQuit
support. However, longer-term abstinence at 6 months
was clinically and statistically significantly higher among
iQuit participants compared with controls. This suggests
that there was a benefit to receiving iQuit support for the
quit attempt planned at enrolment. The findings also
showed that iQuit support was acceptable to most partici-
pants and was feasible to deliver within the context of a
primary care consultation.
Our 6-month prolonged abstinence findings are con-
sistent with the findings from a meta-analysis of mobile
phone cessation intervention trials [8]. Several trials in
this meta-analysis found short-term effects for text mes-
saging interventions. Unlike these trials, however, the
usual care received by the control group in our trial was
fairly intensive. Therefore, the absence of a significant
short-term effect may be due to the effect of usual care. It
is less clear why there were no significant group differ-
ences in 3-month abstinence at the 6-month follow-up.
Given that many quitters in this category would have
experienced an early relapse, it may be that iQuit support
was less helpful for those starting another quit attempt
when a significant portion of iQuit support had already
been delivered.
Self-reported abstinence at 4weeks in the control arm,
based on the UK Department of Health (DH) definition,
was lower than that reported nationally for primary care
settings (2011–12) (trial 26.4%; national 47.8%) [1].
The possibility that the practices participating in the
study did not represent primary care settings nationally
may explain this discrepancy. However, we observed
errors in the data collected from SCAs in our trial which
may have contributed to this discrepancy (errors were
corrected for trial analyses). On 26.0% of occasions (74
of 285 participants self-reporting abstinence), study
SCAs indicated that they would report a participant as a
quitter to the DH when the 4-week follow-up was under-
taken outside the allowed time-frame. Furthermore, for
10.2% of participants (29 of 285) SCAs said they would
report them as quitters despite them reporting smoking
in the last 14 days, contravening the DH definition. Given
that similar discrepancies between research-based and
national abstinence figures have been observed elsewhere
[26], and that it is suspected that leniency is applied to
how service throughput is defined [27], national primary
care abstinence figures for the England SSSs may be arti-
ficially inflated.
A study limitation was that we were not able to
capture accurately the number of individuals
approached informally about the studywho subsequently
decided not to participate. Overall, however, participants
were similar to those who access the SSSs nationally [1],
although they had higher rates of employment (trial
64.6%; national 43.4%) and white ethnic group (trial
98.0%; national 88.3%).
As the final 6-month follow-up was undertaken by
post/telephone and it was not practical to bring partici-
pants into the GP surgery for an additional CO measure,
we did not validate abstinence biochemically at this time-
point. Saliva samples for cotinine assay can be obtained
by post, but there are disadvantages to this, including
being unable to validate prolonged abstinence when col-
lected at one time-point only and unable to validate quit-
ters who continue to use nicotine replacement therapy
(NRT) at follow-up (16.5% of trial participants reporting
6-month prolonged abstinence). While there is little evi-
dence of differential misreporting between trial arms in
smoking intervention studies [28], a risk of bias remains.
One potential solution for a future definitive trial would be
to undertake a verification visit for self-reported quitters
using both CO and salivary cotinine assessments.
This trial has established the feasibility and acceptabil-
ity to smokers in primary care of integrating tailored
printed and text message self-help into routine cessation
support. The findings from a nested acceptability survey
and qualitative interview study, not reported here, also
indicate high acceptability among SCAs in delivering this
intervention during routine consultations (in prepara-
tion). While short-term effectiveness of the iQuit system
was not demonstrated, longer-term smoking outcomes
suggest a clinically significant benefit of adding this type
of tailored self-help to routine care. Overall, the findings
support proceeding to a large definitive trial to establish
long-term effectiveness and cost-effectiveness.
Clinical trial registration
ISRCTN 56702353.
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Supporting information
Additional Supporting Information may be found in the
online version of this article at the publisher’s web-site:
Table S1 Behaviour change techniques applied in the
iQuit in Practice tailored intervention. Based on Michie
et al. [5] Table 1.
Table S2 Text message schedule.
Appendix S1 Tailored advice report.
Appendix S2 Examples of tailored text messages.
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